257 related articles for article (PubMed ID: 29968974)
1. Compared with intensity-modulated radiotherapy, image-guided radiotherapy reduces severity of acute radiation-induced skin toxicity during radiotherapy in patients with breast cancer.
Lin JC; Tsai JT; Chou YC; Li MH; Liu WH
Cancer Med; 2018 Aug; 7(8):3622-3629. PubMed ID: 29968974
[TBL] [Abstract][Full Text] [Related]
2. Volumetric-Modulated Arc Radiotherapy with Daily Image-Guidance Carries Better Toxicity Profile for Higher Risk Prostate Cancer.
Ghanem AI; Elsaid AA; Elshaikh MA; Khedr GA
Asian Pac J Cancer Prev; 2021 Jan; 22(1):61-68. PubMed ID: 33507680
[TBL] [Abstract][Full Text] [Related]
3. Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance.
Nakamura K; Mizowaki T; Inokuchi H; Ikeda I; Inoue T; Kamba T; Ogawa O; Hiraoka M
Int J Clin Oncol; 2018 Feb; 23(1):158-164. PubMed ID: 28756594
[TBL] [Abstract][Full Text] [Related]
4. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
[TBL] [Abstract][Full Text] [Related]
5. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.
Zelefsky MJ; Kollmeier M; Cox B; Fidaleo A; Sperling D; Pei X; Carver B; Coleman J; Lovelock M; Hunt M
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):125-9. PubMed ID: 22330997
[TBL] [Abstract][Full Text] [Related]
6. Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.
Jereczek-Fossa BA; Maucieri A; Marvaso G; Gandini S; Fodor C; Zerini D; Riva G; Alessandro O; Surgo A; Volpe S; Fanetti G; Arculeo S; Zerella MA; Parisi S; Maisonneuve P; Vavassori A; Cattani F; Cambria R; Garibaldi C; Starzyńska A; Musi G; De Cobelli O; Ferro M; Nolè F; Ciardo D; Orecchia R
Med Oncol; 2018 Nov; 36(1):9. PubMed ID: 30483899
[TBL] [Abstract][Full Text] [Related]
7. A phase I/II study piloting accelerated partial breast irradiation using CT-guided intensity modulated radiation therapy in the prone position.
Bergom C; Prior P; Kainz K; Morrow NV; Ahunbay EE; Walker A; Allen Li X; White J
Radiother Oncol; 2013 Aug; 108(2):215-9. PubMed ID: 23932158
[TBL] [Abstract][Full Text] [Related]
8. Exposure Risks Among Children Undergoing Radiation Therapy: Considerations in the Era of Image Guided Radiation Therapy.
Hess CB; Thompson HM; Benedict SH; Seibert JA; Wong K; Vaughan AT; Chen AM
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):978-92. PubMed ID: 27026304
[TBL] [Abstract][Full Text] [Related]
9. Five-year survival outcomes of intensity-modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) using forward IMRT or Tomotherapy for breast cancer.
Lee HH; Chen CH; Luo KH; Chuang HY; Huang CJ; Cheng YK; Chen F; Kuo SH; Huang MY
Sci Rep; 2020 Mar; 10(1):4342. PubMed ID: 32152428
[TBL] [Abstract][Full Text] [Related]
10. Setup errors in cone-beam computed tomography and their effects on acute radiation toxicity in cervical cancer radiotherapy.
Xin S
Genet Mol Res; 2015 Sep; 14(3):10937-43. PubMed ID: 26400321
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced acute toxicities after image-guided intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for patients with spinal metastases (IRON-1 trial) : First results of a randomized controlled trial.
Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; El Shafie R; Nicolay NH; Debus J; Rief H
Strahlenther Onkol; 2018 Oct; 194(10):911-920. PubMed ID: 29978307
[TBL] [Abstract][Full Text] [Related]
12. Impact of postoperative daily image-guided intensity-modulated radiotherapy on overall and local progression-free survival in patients with oral cavity cancer.
Hsieh CH; Shueng PW; Wang LY; Huang YC; Liao LJ; Lo WC; Lin YC; Wu LJ; Tien HJ
BMC Cancer; 2016 Feb; 16():139. PubMed ID: 26906330
[TBL] [Abstract][Full Text] [Related]
13. Reduced late urinary toxicity with high-dose intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer.
Zapatero A; Roch M; Büchser D; Castro P; Fernández-Banda L; Pozo G; Liñán O; Martin de Vidales C; Cruz-Conde A; García-Vicente F
Clin Transl Oncol; 2017 Sep; 19(9):1161-1167. PubMed ID: 28374321
[TBL] [Abstract][Full Text] [Related]
14. Nomogram to predict rectal toxicity following prostate cancer radiotherapy.
Delobel JB; Gnep K; Ospina JD; Beckendorf V; Chira C; Zhu J; Bossi A; Messai T; Acosta O; Castelli J; de Crevoisier R
PLoS One; 2017; 12(6):e0179845. PubMed ID: 28640871
[TBL] [Abstract][Full Text] [Related]
15. Multibeam inverse intensity-modulated radiotherapy (IMRT) for whole breast irradiation: a single center experience in China.
Yang Z; Zhang L; Chen X; Ma J; Mei X; Chen J; Yu X; Guo X
Oncotarget; 2015 Oct; 6(33):35063-72. PubMed ID: 26393681
[TBL] [Abstract][Full Text] [Related]
16. Partial Laryngeal IMRT for T2N0 Glottic Cancer: Impact of Image Guidance and Radiation Therapy Intensification.
Rock K; Huang SH; Tiong A; Lu L; Xu W; Ringash J; Bratman SV; Tong L; Chan B; Cho J; Giuliani M; Hope A; Bayley A; Kim J; de Almeida JR; O'Sullivan B; Waldron J
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):941-949. PubMed ID: 29730062
[TBL] [Abstract][Full Text] [Related]
17. Preoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: report on late toxicity and outcome.
Engels B; Platteaux N; Van den Begin R; Gevaert T; Sermeus A; Storme G; Verellen D; De Ridder M
Radiother Oncol; 2014 Jan; 110(1):155-9. PubMed ID: 24239243
[TBL] [Abstract][Full Text] [Related]
18. Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy: Results of a Phase III Randomised Controlled Trial.
Joseph K; Vos LJ; Gabos Z; Pervez N; Chafe S; Tankel K; Warkentin H; Ghosh S; Amanie J; Powell K; Polkosnik LA; Horsman S; MacKenzie M; Sabri S; Parliament MB; Mackey J; Abdulkarim B
Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):30-39. PubMed ID: 32711920
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experience.
Peeken JC; Knie C; Kessel KA; Habermehl D; Kampfer S; Dapper H; Devecka M; von Eisenhart-Rothe R; Specht K; Weichert W; Wörtler K; Knebel C; Wilkens JJ; Combs SE
Radiat Oncol; 2019 Jan; 14(1):2. PubMed ID: 30626408
[TBL] [Abstract][Full Text] [Related]
20. Long-term Tumor Control and Late Toxicity in Patients with Prostate Cancer Receiving Hypofractionated (2.2 Gy) Soft-tissue-matched Image-guided Intensity-modulated Radiotherapy.
Shimizu D; Yamazaki H; Nishimura T; Aibe N; Okabe H
Anticancer Res; 2017 Oct; 37(10):5829-5835. PubMed ID: 28982908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
